5月22日 - ** Vigil NeuroscienceVIGL.O股价盘前大涨245%至8美元，因为赛诺菲将以4.7亿美元收购 (link)，以扩大其神经系统产品线。
** 赛诺菲将向Vigil股东支付每股8美元，Vigil股东还有资格获得每股2美元的或有价值权$(CVR)$
** CVR 与 Vigil 正在开发的一种可能治疗阿尔茨海默病的药物有关
** Vigil 公司的股票在过去 12 个月中贬值了三分之一，周三收盘时的估值约为 1 亿美元。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.